Bicocca Open Archive

Logo unimib boa
BIONDI, ANDREA
 Distribuzione geografica
Salva come PNG Salva come JPEG
Continente #
NA - Nord America 46.638
EU - Europa 20.882
AS - Asia 11.025
SA - Sud America 647
AF - Africa 104
Continente sconosciuto - Info sul continente non disponibili 52
OC - Oceania 39
Totale 79.387
Salva come PNG Salva come JPEG
Nazione #
US - Stati Uniti d'America 45.942
IT - Italia 4.780
SG - Singapore 4.420
CN - Cina 3.103
RU - Federazione Russa 2.983
SE - Svezia 2.753
DE - Germania 2.741
IE - Irlanda 2.706
HK - Hong Kong 1.859
UA - Ucraina 1.679
GB - Regno Unito 966
CA - Canada 646
BR - Brasile 546
FI - Finlandia 534
FR - Francia 395
VN - Vietnam 384
ID - Indonesia 382
AT - Austria 366
TR - Turchia 263
IN - India 247
NL - Olanda 245
DK - Danimarca 199
BE - Belgio 157
JP - Giappone 69
CH - Svizzera 52
IR - Iran 51
ES - Italia 42
PL - Polonia 41
CZ - Repubblica Ceca 38
EU - Europa 38
RO - Romania 35
BG - Bulgaria 33
AU - Australia 31
PK - Pakistan 30
GR - Grecia 25
KR - Corea 25
AR - Argentina 24
EG - Egitto 22
MX - Messico 22
NO - Norvegia 22
ZA - Sudafrica 22
AE - Emirati Arabi Uniti 21
PH - Filippine 19
MA - Marocco 17
PE - Perù 17
EC - Ecuador 15
LT - Lituania 15
TW - Taiwan 15
CL - Cile 14
IQ - Iraq 14
PT - Portogallo 14
AZ - Azerbaigian 12
BD - Bangladesh 11
IL - Israele 11
UZ - Uzbekistan 10
VE - Venezuela 10
AL - Albania 9
JO - Giordania 9
SA - Arabia Saudita 9
TH - Thailandia 9
LV - Lettonia 8
NG - Nigeria 8
NZ - Nuova Zelanda 8
PA - Panama 8
A2 - ???statistics.table.value.countryCode.A2??? 7
AM - Armenia 7
BO - Bolivia 7
DZ - Algeria 7
KG - Kirghizistan 7
KZ - Kazakistan 7
RS - Serbia 7
SC - Seychelles 7
CO - Colombia 6
GT - Guatemala 6
EE - Estonia 5
LK - Sri Lanka 5
MU - Mauritius 5
PY - Paraguay 5
SK - Slovacchia (Repubblica Slovacca) 5
A1 - Anonimo 4
DO - Repubblica Dominicana 4
HU - Ungheria 4
MK - Macedonia 4
MY - Malesia 4
NP - Nepal 4
OM - Oman 4
RE - Reunion 4
BA - Bosnia-Erzegovina 3
BY - Bielorussia 3
CI - Costa d'Avorio 3
CR - Costa Rica 3
KE - Kenya 3
LA - Repubblica Popolare Democratica del Laos 3
LU - Lussemburgo 3
MN - Mongolia 3
TN - Tunisia 3
GE - Georgia 2
HN - Honduras 2
IM - Isola di Man 2
LB - Libano 2
Totale 79.361
Salva come PNG Salva come JPEG
Città #
Ann Arbor 8.965
Woodbridge 4.519
Fairfield 4.225
Houston 3.487
Singapore 2.854
Chandler 2.783
Dublin 2.608
Wilmington 2.424
Ashburn 2.309
Frankfurt am Main 1.909
Hong Kong 1.843
Jacksonville 1.836
Seattle 1.699
Cambridge 1.460
Milan 1.319
Dearborn 1.266
New York 1.105
Santa Clara 1.089
Princeton 1.003
Nanjing 519
Lawrence 474
Altamura 459
Shanghai 404
Beijing 400
Jakarta 363
Lachine 309
Vienna 290
San Diego 282
Moscow 211
Dong Ket 200
Helsinki 188
Rome 170
Andover 166
Boardman 163
Council Bluffs 156
Toronto 156
Lissone 154
Guangzhou 151
Nanchang 149
Brussels 146
Los Angeles 136
London 132
Nuremberg 132
Hebei 128
Chicago 125
Shenyang 120
Changsha 111
Tianjin 102
Monza 96
Ottawa 93
Jinan 91
Fremont 86
Norwalk 85
Falls Church 82
Hangzhou 78
Jiaxing 76
Fuzhou 68
Zhengzhou 61
Huizen 60
Mountain View 59
São Paulo 58
Bergamo 57
Dallas 57
Pune 57
Bologna 55
Ningbo 55
Turin 55
Kocaeli 53
Kunming 50
Padova 50
Florence 48
Munich 47
Redmond 45
Edmonton 44
Hefei 42
Paris 39
Romola 35
San Mateo 35
Taizhou 33
Bari 29
Grafing 29
Cinisello Balsamo 28
Naples 28
University Park 28
Washington 28
Auburn Hills 26
Como 26
Carate Brianza 24
Chengdu 24
Düsseldorf 24
Lappeenranta 24
Sesto San Giovanni 24
Besana In Brianza 23
Genoa 23
Istanbul 23
Philadelphia 22
Sacramento 22
Perugia 21
Contursi 20
Mumbai 20
Totale 57.565
Salva come PNG Salva come JPEG
Nome #
miRNA-regulated gene expression differs in celiac disease patients according to the age of presentation 435
Intraperitoneal adoptive transfer of mesenchymal stem cells enhances recovery from acid aspiration acute lung injury in mice 406
Prenatal Origin of Pediatric Leukemia: Lessons From Hematopoietic Development 366
Molecular Pathways and Respiratory Involvement in Lysosomal Storage Diseases 363
Enzymatic replacement therapy for Hunter disease: Up to 9 years experience with 17 patients 361
Results of a multicenter universal newborn screening program for sickle cell disease in Italy: A call to action 351
Hepatic granulomatous lesions caused by systemic bartonella vinsonii subsp. arupensis infection in a child 338
Treatment of Graft versus Host Disease with Mesenchymal Stromal Cells: A Phase I Study on 40 Adult and Pediatric Patients 336
First evidence of a paediatric patient with Cornelia de Lange syndrome with acute lymphoblastic leukaemia 330
Acute myeloid leukaemia niche regulates response to L-asparaginase 328
Phase II Study of Sequential Infusion of Donor Lymphocyte Infusion and Cytokine-Induced Killer Cells for Patients Relapsed after Allogeneic Hematopoietic Stem Cell Transplantation 326
NIPBL: a new player in myeloid cells differentiation 321
Clinical features and outcome of SIL/TAL1-positive t-cell acute lymphoblastic leukemia in children and adolescents: A 10-year experience of the AIEOP group 316
Acute Myeloid Leukemia Targeting by Chimeric Antigen Receptor T Cells: Bridging the Gap from Preclinical Modeling to Human Studies 304
Predictive value of minimal residual disease in philadelphia-chromosome-positive acute lymphoblastic leukemia treated with imatinib in the European intergroup study of post-induction treatment of Philadelphia-chromosome-positive acute lymphoblastic leukemia, based on immunoglobulin/T-cell receptor and BCR/ABL1 methodologies 298
Phenotypical and Functional Characterization of Mesenchymal Stem Cells Derived From Patients Affected by Schwachman-Diamond Syndrome 293
Development of advanced therapies in Italy: Management models and sustainability in six Italian cell factories 292
Pentraxin 3 plasma levels at graft-versus-host disease onset predict disease severity and response to therapy in children given haematopoietic stem cell transplantation 291
Late mortality and causes of death among 5-year survivors of childhood cancer diagnosed in the period 1960–1999 and registered in the Italian Off-Therapy Registry 289
Maturation signatures of conventional dendritic cell subtypes in COVID-19 suggest direct viral sensing 289
Hodgkin lymphoma in a patient with mosaic trisomy 18: First clinical observation 285
Immunogenotype changes prevail in relapses of young children with TEL-AML1-positive acute lymphoblastic leukemia and derive mainly from clonal selection 282
Moral distress in nurses in oncology and haematology units 279
ActivinA: a new leukemia-promoting factor conferring migratory advantage to B-cell precursor-acute lymphoblastic leukemic cells 278
Pro-inflammatory cytokines favor the emergence of ETV6-RUNX1-positive pre-leukemic cells in a model of mesenchymal niche 275
Mesenchymal stromal cells for the treatment of graft-versus-host disease: understanding the in vivo biological effect through patient immune monitoring 273
Diagnosis and monitoring of PML-RARA-positive acute promyelocytic leukemia by qualitative RT-PCR 270
Globalization of pediatric research: Pharmacological RCTs in Latin America 270
Prevalence of Immunological Defects in a Cohort of 97 Rubinstein–Taybi Syndrome Patients 270
IKZF1 plus defines a new minimal residual disease-dependent very-poor prognostic profile in pediatric b-cell precursor acute lymphoblastic leukemia 267
Safe and Effective Treatment of Graft Versus Host Disease with Platelet Lysate-Expanded Human Mesenchymal Stromal Cells: A Phase 1 Study On 47 Adult and Pediatric Patients 266
Mesenchymal stromal cells from Shwachman-Diamond syndrome patients fail to recreate a bone marrow niche in vivo and exhibit impaired angiogenesis 266
Preclinical Efficacy and Safety of CD19CAR Cytokine-Induced Killer Cells Transfected with Sleeping Beauty Transposon for the Treatment of Acute Lymphoblastic Leukemia 264
Targeting CD33 in Chemoresistant AML Patient-Derived Xenografts by CAR-CIK Cells Modified with an Improved SB Transposon System 264
Full GMP-Compliant Validation of Bone Marrow-Derived Human CD133+ Cells as Advanced Therapy Medicinal Product for Refractory Ischemic Cardiomyopathy 261
Activin A contributes to the definition of a pro-oncogenic bone marrow microenvironment in t(12;21) preleukemia 260
Sleeping Beauty-engineered CAR T cells achieve anti-leukemic activity without severe toxicities 259
Genomewide Association Study of Severe Covid-19 with Respiratory Failure 257
Children with cancer in the time of COVID-19: An 8-week report from the six pediatric onco-hematology centers in Lombardia, Italy 254
Reduced-Intensity delayed intensification in standard-Risk pediatric acute lymphoblastic leukemia defined by undetectable minimal residual disease: Results of an international randomized trial (AIEOP-BFM ALL 2000) 253
A new case report of severe mucopolysaccharidosis type VII: Diagnosis, treatment with haematopoietic cell transplantation and prenatal diagnosis in a second pregnancy 11 Medical and Health Sciences 1114 Paediatrics and Reproductive Medicine 253
Fludarabine as a cost-effective adjuvant to enhance engraftment of human normal and malignant hematopoiesis in immunodeficient mice 251
From Adjustment to Thriving: Exploring Well-Being in Young Adult Survivors of Childhood Cancer and Their Siblings 248
GMP-grade preparation of biomimetic scaffolds with osteo-differentiated autologous mesenchymal stromal cells for the treatment of alveolar bone resorption in periodontal disease 245
A simple RNA target capture NGS strategy for fusion genes assessment in the diagnostics of pediatric B-cell acute lymphoblastic leukemia 245
The histone deacetylase inhibitor givinostat (ITF2357) exhibits potent anti-tumor activity against CRLF2-rearranged BCP-ALL 244
Acute myeloid leukemia shapes the bone marrow stromal niche in vivo 244
Regulatory T cells and extracorporeal photochemotherapy: correlation with clinical response and decreased frequency of proinflammatory T cells. 243
Balance of Anti-CD123 Chimeric Antigen Receptor Binding Affinity and Density for the Targeting of Acute Myeloid Leukemia 243
Helmet CPAP to treat hypoxic pneumonia outside the ICU: an observational study during the COVID-19 outbreak 242
Oral nutritional supplementation in children treated for cancer in low- and middle-income countries is feasible and effective: The experience of the children's hospital manuel de jesus rivera "la mascota" in Nicaragua 240
Studio preliminare sul profilo emotivo di un campione di bambini guariti da leucemia linfoblastica acuta 240
Human umbilical cord blood-borne fibroblasts contain marrow niche precursors that form a bone/marrow organoid in vivo 239
T cells stimulated by CD40L positive leukemic blasts-pulsed dendritic cells meet optimal functional requirements for adoptive T-cell therapy 236
Immunotherapy of acute leukemia by chimeric antigen receptormodified lymphocytes using an improved Sleeping Beauty transposon platform 235
A novel EP300 mutation associated with Rubinstein-Taybi syndrome type 2 presenting as combined immunodeficiency 235
AIEOP-BFM consensus guidelines 2016 for flow cytometric immunophenotyping of Pediatric acute lymphoblastic leukemia 235
Antileukemic efficacy of BET inhibitor in a preclinical mouse model of MLL-AF4 + infant ALL 231
Asparagine levels in the cerebrospinal fluid of children with acute lymphoblastic leukemia treated with pegylated-asparaginase in the induction phase of the AIEOP-BFM ALL 2009 study 230
Epigenetic silencing of BIM in glucocorticoid poor-responsive pediatric acute lymphoblastic leukemia, and its reversal by histone deacetylase inhibition 227
Antitumour activity of trabectedin in myelodysplastic/myeloproliferative neoplasms 226
Interleukin-17-producing t-helper cells as new potential player mediating graft-versus-host disease in patients undergoing allogeneic stem-cell transplantation 225
Autologous Purified Peripheral Blood Stem Cell Transplantation Compare to Chemotherapy in Childhood Acute Lymphoblastic Leukemia after Low-Risk Relapse 225
Stable Expression Of Chimeric Antigen Receptors (CARs) By Sleeping Beauty-Mediated Gene Transfer and Efficient Expansion Of Leukemia-Specific Cytokine-Induced Killer (CIK) Cells 223
How I treat infant leukemia 223
Absent B cells, agammaglobulinemia, and hypertrophic cardiomyopathy in folliculin-interacting protein 1 deficiency 223
Drug-induced immunophenotypic modulation in childhood ALL: implications for minimal residual disease detection 222
Transposon-Based CAR T Cells in Acute Leukemias: Where are We Going? 219
Two siblings presenting with novel ADA2 variants, lymphoproliferation, persistence of large granular lymphocytes, and T-cell perturbations 217
Characterization of in vitro migratory properties of anti-CD19 chimeric receptor-redirected CIK cells for their potential use in B-ALL immunotherapy 216
A second update on mapping the human genetic architecture of COVID-19 215
Location First: Targeting Acute Myeloid Leukemia Within Its Niche 215
Human aplastic anaemia-derived mesenchymal stromal cells form functional haematopoietic stem cell niche in vivo 214
TNFRSF13C (BAFFR) positive blasts persist after early treatment and at relapse in childhood B-cell precursor acute lymphoblastic leukaemia 214
Mesenchymal stromal cell-secreted chemerin is a novel immunomodulatory molecule driving the migration of ChemR23-expressing cells 214
Mesenchymal stromal cell-derived PTX3 promotes wound healing via fibrin remodeling 214
Optimization of PCR-based minimal residual disease diagnostics for childhood acute lymphoblastic leukemia in a multi-center setting 213
Platelet-lysate-expanded mesenchymal stromal cells as a salvage therapy for severe resistant graft-versus-host disease in a pediatric population 212
Engineered T cells towards TNFRSF13C (BAFFR): a novel strategy to efficiently target B-cell acute lymphoblastic leukaemia 210
Mesenchymal stromal cells do not increase the risk of viral reactivation nor the severity of viral events in recipients of allogeneic stem cell transplantation 209
Repeated infusions of donor-derived cytokine-induced killer cells in patients relapsing after allogeneic stem cell transplantation: A phase I study 207
Early diagnosis of PI3Kδ syndrome in a 2 years old girl with recurrent otitis and enlarged spleen 207
Cytoskeletal Regulatory Gene Expression and Migratory Properties of B Cell Progenitors are Affected by the ETV6-RUNX1 Rearrangement 205
PO-345 Long-Term Survivors of Childhood Acute Lymphoblastic Leukaemia (ALL):Does Parents’Emotional Well-being Affect the Emotional Disposition of Their Survived Children? 205
Characterization of CD34+, CD13+, CD33- cells, a rare subset of immature human hematopoietic cells 204
Development of a quantitative-PCR method for specific FLT3/ITD monitoring in acute myeloid leukemia 203
PAX5/TEL acts as a transcriptional repressor causing down-modulation of CD19, enhances migration to CXCL12, and confers survival advantage in pre-BI cells 202
Pharmacodynamic effects in the cerebrospinal fluid of rats after intravenous administration of different asparaginase formulations 202
An immune-based biomarker signature is associated with mortality in COVID-19 patients 202
Acute myeloid leukemia and novel biological treatments: Monoclonal antibodies and cell-based gene-modified immune effectors 201
Crescere dopo il tumore: Le emozioni dei bambini guariti da leucemia linfoblastica acuta a confronto con quelle di altre popolazioni 201
Inhibition of the ABL kinase activity blocks the proliferation of BCR/ABL+ leukemic cells and induces apoptosis 201
Chimeric T-cell receptors: New challenges for targeted immunotherapy in hematologic malignancies 200
Minimal residual disease-directed risk stratification using real-time quantitative PCR analysis of immunoglobulin and T-cell receptor gene rearrangements in the international multicenter trial AIEOP-BFM ALL 2000 for childhood acute lymphoblastic leukemia 200
Mapping the human genetic architecture of COVID-19 200
Efficient detection of leukemia-related fusion transcripts by multiplex PCR applied on a microelectronic platform 199
Highly sensitive mutations detection in BCR-ABL positive leukemia prior and during imatinib treatment 199
Long-term follow up of pediatric Philadelphia positive acute lymphoblastic leukemia treated with the EsPhALL2004 study: High white blood cell count at diagnosis is the strongest prognostic factor 199
Neonatal combination therapy improves some of the clinical manifestations in the Mucopolysaccharidosis type I murine model 199
Extracorporeal photochemotherapy is accompanied by increasing levels of circulating CD4+CD25+GITR+Foxp3+CD62L+ functional regulatory T-cells in patients with graft-versus-host disease. 197
Totale 25.174
Salva come PNG Salva come JPEG
Categoria #
all - tutte 305.510
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 305.510
Salva come PNG Salva come JPEG


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2019/20201.843 0 0 0 0 0 0 0 0 0 711 799 333
2020/202111.714 571 772 1.243 1.147 881 1.045 1.103 1.075 915 1.207 725 1.030
2021/20227.503 529 839 954 528 429 516 350 389 572 540 597 1.260
2022/202311.443 1.435 3.409 836 1.011 707 1.702 194 681 748 95 410 215
2023/20248.951 310 290 438 479 1.139 2.268 1.640 318 756 190 282 841
2024/202514.819 1.151 2.332 1.267 1.023 1.856 899 1.489 801 2.275 1.726 0 0
Totale 82.307